Clinical Trials Results - National Cancer Institute

Skip to content

NCI Home

Cancer Topics

Clinical Trials

Cancer Statistics

Research & Funding

News

About NCI


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -4 of 4 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 5/18/2007 First Published: 7/1/2002


1.		Phase III Randomized Study of Docetaxel With or Without Infliximab in Elderly or Poor Performance Status Patients With Wasting, Anorexia, and Asthenia Related to Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Closed				Adult				NCI				NCCTG-N01C9 NCI-P02-0226, N01C9, NCT00040885

Last Modified: 12/5/2007 First Published: 11/20/2003


2.		Phase II Randomized Study of Infliximab in Patients With Low- or Intermediate-Risk Myelodysplastic Syndromes

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				Other				EORTC-06023 NCT00074074


3.		A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Pancreatic Cancer Related Cachexia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care				Completed				18 and over				Pharmaceutical / Industry				CR004798 NCT00060502

Last Modified: 9/11/2008 First Published: 5/29/2008


4.		Study of the Effects of Immune-Modulating Therapies on Tissue Expression of Indoleamine 2, 3 dioxygenase in Patients With Untreated Acute or Chronic Hepatitis C, Metastatic Melanoma, or Crohn Disease

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Biomarker/Laboratory analysis				Completed				No age specified				NCI				VU-VICC-MEL-0651 VICC-MEL-0651, VU-VICC-060614

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute